Clinical Trials Browser

Lymphoma, T-Cell, Peripheral × Gemcitabine × 30 days × Clear all

NCT04984837 2026-06-04

Study of Lacutamab in Peripheral T-cell Lymphoma

Phase 2 Active not recruiting

Recurrence, Lymphoma, T-Cell, Lymphoma, T-Cell, Peripheral